Lumos Pharma to Announce Q1 2024 Results and Clinical Update on May 15, 2024

AUSTIN, Texas, May 09, 2024 – Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical firm concentrating on treatments for rare diseases, has announced it will release its financial results for the first quarter of 2024 before the market opens on Wednesday, May 15, 2024. Following the release, the company will conduct a conference call and webcast at 8:30 AM ET to discuss the financial outcomes and to provide updates on clinical and corporate activities, followed by a question-and-answer session.

Details for the Conference Call and Webcast are as follows:
- Date: Wednesday, May 15, 2024
- Time: 8:30 AM ET
- Dial-in Numbers: 1-877-407-9716 (US) or 1-201-493-6779 (International)
- Conference ID: 13746447
- Dial-in registration: Available 15 minutes before the scheduled start time
- Webcast: Accessible via the "Investors & Media" section on Lumos Pharma’s website under "Events & Presentations"

Investors and the public are welcome to listen to the call. To ensure timely access, participants are advised to dial in ten minutes before the start time. The webcast link is also available on Lumos Pharma's website. A replay of the call will be available afterward through the same link.

Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing therapeutic solutions for rare diseases. The company is led by an experienced management team with extensive background in rare disease drug development. Its leading therapeutic candidate, LUM-201, is an innovative, oral growth hormone (GH) secretagogue aiming to revolutionize the approximately $3.4 billion global GH market by shifting from injectable to oral therapy. LUM-201 is currently undergoing several Phase 2 clinical trials for Pediatric Growth Hormone Deficiency (PGHD) and has received Orphan Drug Designation in both the United States and the European Union.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!